Participating Faculty: Exploring Novel Management Options for Alopecia Areata

Faculty

Libbi Green, PharmD

Formulary Manager

Clinical Operations

Capital Rx

New York, NY

Emma Guttman, MD, PhD

Waldman Professor of Dermatology and Immunology

Health System Chair

The Kimberly and Eric J. Waldman Department of Dermatology

Director, Center of Excellence in Eczema

Laboratory of Inflammatory Skin Diseases

Icahn School of Medicine at Mount Sinai

New York, NY

Mark Lebwohl, MD

Professor and Chairman Emeritus

The Kimberly and Eric J. Waldman Department of Dermatology

Dean, Clinical Therapeutics

Icahn School of Medicine at Mount Sinai

New York, NY

Benjamin Ungar, MD

Director, Alopecia Center of Excellence

The Kimberly and Eric J. Waldman Department of Dermatology

Icahn School of Medicine at Mount Sinai

New York, NY

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Libbi Green, PharmD, has no relevant commercial financial relationships or affiliations to disclose.

Emma Guttman, MD, PhD

CONSULTANCIES OR PAID ADVISORY BOARDS

Sanofi

GRANTS RECEIVED

AbbVie, Aclaris Therapeutics, Amgen, AnaptysBio, Apollo Therapeutics, Arcutis Biotherapeutics, Bristol Myers Squibb, Concerto Biosciences, Galderma, GSK, ImageneBio, InCyte, LEO Pharma, Lilly, Opsidio, Pfizer, Regeneron, Sanofi, Xencor, and Q32 Bio.

Mark Lebwohl, MD

CONSULTANCIES OR PAID ADVISORY BOARDS

AbbVie, Added Health, Aikium, Almirall, AltruBio, Alumis, Amgen, Apogee, Arcutis Biotherapeutics, AstraZeneca, Atomwise, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Castle Biosciences, Celltrion, Corevitas, Dermavant Sciences, Dermsquared, Edessa, Evommune, Facilitation of International Dermatology Education, Forte Biosciences, Galderma, Genentech, Johnson & Johnson, InCyte, LEO Pharma, Lilly, Mayne Pharmaceuticals, Meiji Seika Pharma, Mindera, Mirium Pharmaceuticals, Moonlake Immunotherapeutics, Oruka Therapeutics, Pfizer, Revolo Biotherapeutics, Sanofi-Regeneron, Seanergy Dermatology, Strata Oncology, Sun Pharma, Takeda, Trevi Therapeutics, and Verrica Pharmaceuticals.

GRANTS RECEIVED

AbbVie, Arcutis Biotherapeutics, Avotres, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Clexio Biosciences, Dermavant Sciences, InCyte, Inozyme Pharma, Johnson & Johnson, Lilly, Oruka Therapeutics, Pfizer, Sanofi-Regeneron, and UCB.

HONORARIA

Aikium, Almirall, AltruBio, Amgen, Apogee, Arcutis Biotherapeutics, AstraZeneca, Atomwise, Avotres, Boehringer Ingelheim, Bristol Myers Squibb, Castle Biosciences, Celltrion, CorEvitas Clinical Registries, Dermavant Sciences, Dermsquared, Evommune, Forte Biosciences, Galderma, Genentech, GoodRx–Mayne Pharma, InCyte, International Dermatology Education Foundation, LEO Pharma, Meiji Seika Pharma, Mindera, Mirum, Oruka Therapeutics, Pfizer, Revolo Biotherapeutics, Sanofi-Regeneron, Seanergy Dermatology, Stratpharma, Sun Pharma, Takeda, Trevi Therapeutics, and Verrica Pharmaceuticals.

Benjamin Ungar, MD

GRANTS RECEIVED

Bristol Myers Squibb, InCyte, Pfizer, Rapt Therapeutics, and Sanofi.

CONSULTANCIES OR PAID ADVISORY BOARDS

AbbVie, Arcutis Biotherapeutics, Apogee, Bristol Myers Squibb, Botanix Pharmaceuticals, Castle Biosciences, Ebla Holdco, Fresenius Kabi, Galderma, Johnson & Johnson, Leo Pharma, Lilly, Nektar Therapeutics, Pfizer, Primus Pharmaceuticals, Sanofi, Sun Pharma, UCB, Veradermics, and VRG Therapeutics.